Two From Yale Are Named Allen Distinguished Investigators
Megan C. King, PhD, associate professor of cell biology and of molecular, cellular and developmental biology, and Simon Mochrie, PhD, professor of physics and of applied physics, have been named Allen Distinguished Investigators by The Paul G. Allen Frontiers Group, a division of the Allen Institute.
$11.5M Grant Supports Study of Linkage To Community-Based Opioid Addiction and HIV Prevention and Treatment Services for Persons Released From Prison
$11.5M Grant Supports Study of Linkage To Community-Based Opioid Addiction and HIV Prevention and Treatment Services For Persons Released From Prison
NIH Supports Two Yale-based Projects to Address COVID-19 Population Disparities
The National Institutes of Health (NIH) has provided research support to two members of the Yale School of Medicine faculty through its Rapid Acceleration of Diagnostics (RADx) initiative, which seeks to speed innovation in the development, commercialization, and implementation of technologies for COVID-19 testing.
Yale Designates Labs in Three States to Provide SalivaDirect™ COVID-19 Test
Three independent laboratories will now join Yale Pathology Labs as facilities authorized to perform the university-developed SalivaDirect™ COVID-19 test. The laboratories will make SalivaDirect™ available to people in Florida, Minnesota, and New York.Source: YaleNews
Yale Partners With Connecticut Department of Education to Launch Instructional COVID-19 Website
A group of volunteers from Yale School of Medicine and educators across the state have come together in a collaboration to create COV-Ed, an online resource tool for educators and students to learn about the challenges of the pandemic.
Yale Researchers to Lead $52M Investigation Into Cause, Effect of Schizophrenia in Some High-risk Adolescents
Researchers with the Yale Department of Psychiatry will lead an international study to better understand the cause and effect of schizophrenia in some high-risk adolescents and young adults.
Drugging the Undruggable: Yale Finds Treatment Path for Muscular Dystrophy
Researchers at Yale have identified a possible treatment for Duchenne muscular dystrophy (DMD), a rare genetic disease for which there is currently no cure or treatment, by targeting an enzyme that had been considered “undruggable.”Source: YaleNews
Quick and Affordable Saliva-based COVID-19 Test Developed by Yale Scientists Receives FDA Emergency Use Authorization
A saliva-based laboratory diagnostic test developed by researchers at the Yale School of Public Health to determine whether someone is infected with the novel coronavirus has been granted an emergency use authorization by the U.S. Food and Drug Administration (FDA).Source: YaleNews